Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kern

Showing results (551-560 of 555) with videos related to

Pageof 56
Sort By:
You have reached the last page of results.This site can display upto 555 results.
Nature Nanotechnology|July 19, 2022
Nanomedicine platform for targeting activated neutrophils and neutrophil-platelet complexes using an α<sub>1</sub>-antitrypsin-derived peptide motifMichelle A Cruz, Dillon Bohinc, Elizabeth A Andraska, et al.
BMJ Open|August 17, 2022
Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)Fiona James, Michelle S Y Goh, Effie Mouhtouris, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 7, 2012
Diagnostics of autoimmune bullous diseases in German dermatology departmentsNina van Beek, Diana Knuth-Rehr, Peter Altmeyer, et al.
The World Allergy Organization Journal|August 30, 2024
The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) - Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptionsFiona James, Michelle S Goh, Sara Vogrin, et al.
Nature|April 7, 2022
Brain charts for the human lifespanR A I Bethlehem, J Seidlitz, S R White, et al.
Pageof 56

Showing results (551-560 of 555) with videos related to

Sort By:
Pageof 56
You have reached the last page of results.This site can display upto 555 results.
Nature Nanotechnology|July 19, 2022
Nanomedicine platform for targeting activated neutrophils and neutrophil-platelet complexes using an α<sub>1</sub>-antitrypsin-derived peptide motifMichelle A Cruz, Dillon Bohinc, Elizabeth A Andraska, et al.
BMJ Open|August 17, 2022
Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)Fiona James, Michelle S Y Goh, Effie Mouhtouris, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 7, 2012
Diagnostics of autoimmune bullous diseases in German dermatology departmentsNina van Beek, Diana Knuth-Rehr, Peter Altmeyer, et al.
The World Allergy Organization Journal|August 30, 2024
The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) - Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptionsFiona James, Michelle S Goh, Sara Vogrin, et al.
Nature|April 7, 2022
Brain charts for the human lifespanR A I Bethlehem, J Seidlitz, S R White, et al.
Pageof 56